Paul W. Barone, PhD MIT

Dr. Paul W. Barone has been at the MIT Center for Biomedical Innovation since 2010. He is currently the Director of the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) and Co-director of Biomanufacturing Initiatives at MIT’s Center for Biomedical Innovation (CBI). The CAACB is a pre-competitive biopharmaceutical industry consortium focused on identifying and sharing best practices to mitigate the risk of adventitious agent contamination in biopharmaceutical manufacturing. Dr. Barone also manages a variety of sponsored research activities related to biopharmaceutical manufacturing, including the development of novel analytical technologies for the rapid assessment of protein product quality, the development of a process for the continuous production of viral vectors, and the development of a training course for cell therapy manufacturing personnel.